INTRODUCTION
Genus Acinetobacter are cause of infections in hospitalised patients and especially those in Intensive Care Unit (ICU) [1] . Due to Acinetobacter spp. biofilm producing ability, they survive longer on dry surfaces or on instruments and disseminate in hospital environments and cause nosocomial infections [2] . This organism is the cause of hospital infections which occur in most disabled ICU patients. Presence of resistance genes among in Acinetobacter spp. make them more prevalent in healthcare settings [3] . The most common Acinetobacter spp. isolated from human samples is Acinetobacter baumannii [4] .
This bacterium is resistant to many available antibiotics because it has been in contact with other gram-negative bacteria in hospital environments and also exposed to extensive bombardment with antibiotics, so most strains of A. baumannii are resistant to ampicillin, tetracycline, rifampin, amoxicillin/clavulanic acid, macrolides, antistaphylococcal penicillin, and wide range cephalosporins except for cefepime, ceftazidime, and chloram phenicol [5] . Therefore, it can acquire resistance mechanisms from plasmids, integrons, transposons, and other gram-negatives, in addition to its inherent tendency to acquire resistance [3] .
Today, Multiple Drug Resistance (MDR) and especially ExtensivelyDrug Resistant (XDR) pathogen are global issues [1] . Usually it is called MDR Acinetobacter when it is resistant to three or more groups of antibiotics or to one key treatment antibiotic, and is Pan Drug-Resistant (PDR) Acinetobacter when it is resistant to all available groups of antibiotics for the experimental treatment of its infections [6] .
Emergence of b-lactamases among bacteria has caused resistance in many bacteria responsible for hospital infections, and has therefore caused serious problems in treating bacterial infections [7] . Production of carbapenemase is mostly the mech anism for resistance to carbapenems. Carbapenem re sistance in A. baumannii is mediated by presence of bla , bla OXA-24-, and bla OXA-58 type of class D family of serine b-lactamases and IMP/VIM class B of metallo-b-lactamases [8] . Mostly the isolates of Acinetobacter spp. have multiple copies of Insertion Sequence (IS) [9] . IS Aba1 and other IS, are on the upstream of OXA type class D carbapenemases and modulates the expression and transfer of OXA-type carbapenemase genes [10] . Resistance of antimicrobial agents among clinical isolates may add to the burden of treating infections and also negatively affect clinical results and treatment costs [2, 11] .
In addition to the ability to acquire resistance indicators by strains of A. baumannii, another issue adding to the clinical importance of these bacteria in the last 15 years which threatens antibiotic therapy is their ability to form biofilm [12] . In fact, biofilm formation ability is an important strategy in their survival, and increases their resistance to antimicrobial compounds under stress such as host defense or antibiotic use [13] .
The present study was conducted in Rasool Akram and Shahid Motahhari Hospitals in order to determine the frequency of resistance to b-lactam antibiotics; the preva lence of different b-lactamases genes and relationship between expression of antibiotic resistance and biofilm formation in strains of A. baumannii isolated from burn wounds and Ventilator Associated Pneumonia (VAP) infections. and gyrB were tested using PCR for genotypic confirmation of isolates. After genotypic and phenotypic confirmation of samples, isolates were moved to an environment of 15% glycerol and 5% liquid Brain-Heart Infusion (BHI) medium (Conda, Spain) for storage and preservation at -70°C.
MATERIALS AND METHODS

Studied Population, Phenotypic and Genotypic Confirmation of Isolates
Antimicrobial Susceptibility Testing
Antibiotic sensitivity pattern with antibiotic disks (Mast, UK) imipenem (10 µg), meropenem (10 µg), cefepime (30 µg), piperacillin/ tazobactam (100/10 µg) , ampicillin/sulbactam (10/10 µg), piperacillin (100 µg), ticarcillin/clavulanic acid (75/10 µg), ceftazidime (30 µg), and ceftriaxone (30 µg) was assessed using agar disc diffusion test according to the recommendations and definitions of the manufacturers and CLSI 2015 guidelines [14] . Minimum Inhibitory Concentration (MIC) against Colistin was determined using E-test (AB BIODISK, Sweden For all other PCR amplification, the product obtained were considered positive based on amplification size and direct sequencing of selected amplicons. In negative result, PCR amplification was repeated at least twice for these genes.
PCR was carried out with 50 ng of the template DNA, 10 pmol of each primer, 1 X PCR buffer, 2.5 mM MgCl 2 , 0.2 mM dNTP mix, and 1U of Taq DNA polymerase (Fermentas, Lithuania) in a total volume of 25 µl. PCR amplification was carried out under the following conditions: 30 cycles of denaturation at 95°C for 30 seconds, annealing at primer set specific temperatures for one minute, and extension at 72°C for one minute followed by a final extension cycle at 72°C for 10 minute. PCR products were resolved on 1.0% agarose gels (Roche, Switzerland), stained with ethidium bromide and photographed with UV illumination.
Biofilm Formation Assay
First, an 18-24 hour colony was added to a tube with Lysogeny Broth medium (LB medium) (Conda, Spain). After 18-24 hour of incubation, its concentration was regulated to use to spectrophotometer at 650 nm, 0.1-0.08. About 190 µl of LB medium and 10 µl of microbial suspension were added into each well of a 96-well microplate and incubated in 37°C for 24-48 hour.
Biofilm formation assay was conducted three times for each bacterium. Negative control for each bacterium had 200 µl of LB medium. After rinsing microplates with distilled water, each well was stained using 0.1% crystal violet for 10 minute at room temperature, and then rinsed three more times with distilled water.
In the last step, 200 µl of 95% ethanol was added to each well, and light absorption at 492 nm was assessed using ELISA reader.
Light absorption values were considered as indicators of bacteria's link to the surface and formation of biofilm. For quantitative analysis of biofilm formation, mean light absorption of three wells (A) was calculated, compared with that of a control well (Ac), and then assessed as: no biofilm formation, A ≤ Ac; weak biofilm formation, Ac < A ≤ (2×Ac); average biofilm formation, (2×Ac) < A ≤ (4×Ac); and strong biofilm formation, (4×Ac) < A.
STATISTICAL ANALySIS
Chi-square analysis and Fisher's exact test using SPSS, version 21.0. were employed for statistical analyses. A p-value < 0.05 were employed as statistically significant.
RESULTS
Antimicrobial Susceptibility Test
All 103 samples had inherent gyrB and bla OXA-51 genes, identified as A. baumannii. These isolates were 93.2% resistant to meropenem, 90.3% to imipenem, 88.3% to cefepime, 87.4% to ceftazidime, 82.4% to ceftriaxone. The highest resistance in clinical isolates of A. baumannii was against meropenem (93.2%), and the lowest resistance was against ampicillin/sulbactam (28.2%). MIC range for colistin was 0.064 µg/ml to 1024 µg/ml of concentration, and MIC50 for ventilated patients and MIC90 for burn patients were 0.125 µg / ml and 0.5 µg /ml for this antibiotic respectively [Table/ Fig-2 ].
Frequency of Antibiotic-resistant and Insertion Elements Genes
Frequencies of bla 
Biofilm Formation
Results of biofilm formation study showed that all (100%) isolated strains tended to form biofilm. Frequency of ability of strong biofilm, average biofilm and weak biofilm formation in clinical A. baumannii strains were 37.8%, 37.9% and 24.3% respectively. In this study, biofilm formation was investigated in resistant, intermediate and sensitive strains; based on results and on statistical analysis, there was no significant relationship between the amount of biofilm formation using microtiter plate and resistance to studied antibiotics (p=0.13). Nevertheless, the amount of biofilm formation was higher in resistant strains compared with sensitive strains [Table/ Fig-5] .
DISCUSSION
A. baumannii shows resistance to most b-lactam antibiotics and quinolones due to its ability to survive in hospital environments, Relationship between the amount of biofilm formation using microtiter plate and resistance to studied antibiotics.
create resistance mechanism, and cause severe infections in patients. Its resistance to aminoglycosides is also emerging [19, 20] . Extensive use of antibiotics has increased antibiotic resistance in this bacterium, so it is reported to be resistant to b-lactamases all over the world [21] . Wide range b-lactamases have different prevalence rates not only among different countries, but also in various geographical regions of one country [22] . Results of bla OXA-51 gene proliferation in this study showed that it existed in all isolates. Prevalence of bla OXA-51 among strains of A. baumannii has been reported by various studies to be 84.37% in Iran [23] , 50% in Taiwan [24] , 82.94% in UK [25] and 100% in a study from Iran [26] . In addition to the bla OXA-51 gene PCR, results of gyrB gene PCR were also used in this study for genotypic confirmation. Results of gyrB gene proliferation demonstrated that it was present in all isolates, perfectly compatible with Higgins P et al., [16] . According to our results, PCR detection of gyrB gene can be a cheaper, easier, and more accurate method compared to other genotypic-based diagnosis methods.
The highest antibiotic resistance observed in this study was against Imipenem (90.3%) and Meropenem (93.2%) which increased over time. Moradi J et al., in their review reported resistance to Imipenem and Meropenem in Iran in 2012-2014 to be 76.5% and 81.5% respectively which was increased over time [27] . Their study showed that many species of A. baumannii have at least two carbapenemase genes simultaneously: bla OXA-51 which is inherent to this bacterium; bla , bla , and bla OXA-23 which are acquired.
In the present study, bla gene was present in 90.3% of A. baumannii strains. In another study done by Sohrabi N et al., was reported in 88.7% of imipenem resistant strains, which was closer to our results [28] . The high prevalence of bla OXA-23 is compatible with global reports which estimate it to be 70-100% [26, 29, 30] .
In our study, 38.9% of strains had bla OXA-24 and 1% had bla OXA-58 . 32% carried both bla and bla , and 1% carried bla OXA-58 and bla . All resistant or sensitive strains carried bla . In another study, none of the strains had bla , and IS Aba1-OXA-51 was found in four strains without any bla OXA-58 , bla , or bla OXA-40 genes [31] .
Different results of studies can be attributed to assessment of different hospitals. Studies from all over the world show that numerous geographical differences have been observed in molecular epidemiology of carbapenemase genes. In the present study, 54.4% of strains with only bla OXA-23 oxacillinase gene and without other oxacillinase genes were resistant to both imipenem or meropenem or one of them indicating the prominent role of this gene in resistance or decreasing sensitivity of A. baumannii against carbapenems. Of course, we must consider three strains which were sensitive to both carbapenems in spite of carrying carbapenemase gene, similar to a study from China in which, 14 carbapenem sensitive A. baumannii strains harboring the bla OXA−51 like gene showed no resistance to carbapenem drugs [32] . Since resistance to Ceftazidime, Imipenem, and Meropenem was also high in this study strains were investigated for the presence of insertion elements as well. Results showed that 69.9% and 56.3% of strains had IS Aba1 and IS 1113 insertion elements respectively.
Sohrabi N et al., reported the prevalence of IS Aba1 gene to be 90% in Iran [28] . Moreover, its prevalence was reported to be 69% by Rezaee MA et al., [33] . In addition, a 2010 study in 10 hospitals in Taiwan showed that 40.2% of 291 A. baumannii isolates included IS Aba1 , and the prevalence of bla OXA-51 IS Aba1 insertion element differed between 6.7% to 64.3% in different hospitals [34] .
In the present study, bla GIM, IMP, SIM and bla VIM genes were assessed using PCR in order to investigate the role of metallo-b-lactamases and determine the frequency of productive strains. As expected, none of these genes were identified.
In a study from Tehran, Shahcheraghi F et al., reported that 9% of Acinetobacter produced metallo-b-lactamase (using combined disk method), yet no gene was separated in PCR [35] The present study showed a decreased sensitivity to most available antimicrobial agents for the treatment of Acinetobacter infections, except for Colistin and Ampicillin/sulbactam, which can be introduced as choice drugs for treating resistant strains. Among Imipenem-and Meropenem-resistant strains, 54.4% carried bla ; therefore, the high prevalence of class D carbapenemases among these isolates may be responsible for resistance to studied carbapenems.
Investigating biofilm formation pattern showed that all strains could form biofilm. Since ventilators are highly involved in Acinetobacter infections, disinfection and sterilization of respiratory equipment and devices can be one way to prevent dissemination of these infections.
LIMITATION
In present study, the sample size was very small to conclude significant results also, only burn and VAP cases were included which do not reveal much about the resistant genes distribution in other infections caused by Acinetobacter baumannii. Also, pattern of spread of resistance among isolates was not studied in current study which would help in infection control. Thus, further studies are needed to be done to study resistance spread pattern among isolates to control such infections in healthcare settings.
CONCLUSION
The present study showed that the presence of insertion elements, co-existence of two or more resistance genes and biofilm producing genes, increases the resistance of isolates. bla OXA-23 and bla TEM are major resistance gene among Acinetobacter isolates. Colistin and ampicillin/sulbactam are treatment choices left for such resistant isolates. Finally, due to extension of antibiotic resistance, identified by the current study, performance of a precise and regular national program to control the immethodical consumption of antibiotics is suggested.
